# Oral Dosage Form New Animal Drugs; Marbofloxacin Tablets
> **Food and Drug Administration** · Final rule. · Published 2001-09-05 · Effective 2001-09-05 · 66 FR 46369
## Document
- **Document number:** 01-22165
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 46369
- **CFR reference:** 21 CFR 520
- **Publication date:** 2001-09-05
- **Effective date:** 2001-09-05
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for the use of marbofloxacin tablets in cats for the treatment of infections associated with bacteria susceptible to marbofloxacin.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/09/05/01-22165/oral-dosage-form-new-animal-drugs-marbofloxacin-tablets)
---
*AI Analytics · CC0 1.0*